Acupuncture and allergic rhinitis

Taw, Malcolm B.; Reddy, William D.; Omole, Folashade; Seidman, Michael D.

doi:10.1097/moo.0000000000000161

Cited by 17 publications

(12 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although there has been a recent increase in interest among the general population regarding complementary and alternative medicine (CAM) approaches, including acupuncture, traditional Chinese medicine, and homeopathy, there is a paucity of randomized controlled studies evaluating these approaches. Acupuncture has the greatest amount of data and shows promise in smaller randomized studies 47 – 50 . Several review articles have been published on the topic of CAM and its role in treating allergic disease, including AR 51 – 53 .…”

Section: Management Of Allergic Rhinitismentioning

confidence: 99%

Recent advances in allergic rhinitis

2018

View full text Add to dashboard Cite

Allergic rhinitis affects 20 to 30% of adults in both the United States and Europe and perhaps a somewhat higher percentage of children. In addition to nasal and ocular symptoms directly related to the allergic process, interference of these symptoms with sleep leads to daytime sleepiness and impaired quality of life. Patients miss work because of symptoms but an even greater problem is interference with work productivity, or presenteeism, which has been reported to be the biggest contributor to the total economic cost of allergic rhinitis. There has been increasing awareness that many patients with either seasonal or perennial symptoms but negative skin and in vitro tests for allergen sensitivity have local nasal allergy, diagnosable by the presence of allergen-specific IgE in their nasal secretions or a positive nasal allergen challenge or both. The pharmaceutical management of allergic rhinitis rests on symptomatic treatment with antihistamines that perhaps are more effectively administered intranasally than orally and intranasal corticosteroids. Allergen immunotherapy is very effective, even for local allergic rhinitis, and the shortcomings of subcutaneous immunotherapy of inconvenience and safety are reduced by the introduction of sublingual immunotherapy (SLIT). Use of the latter is currently somewhat limited by the lack of appropriate dosing information for SLIT liquids and the limited number of allergens for which SLIT tablets are available.

show abstract

Section: Management Of Allergic Rhinitismentioning

confidence: 99%

Recent advances in allergic rhinitis

2018

View full text Add to dashboard Cite

show abstract

“…Acupuncture has been proven to exert anti-inflammatory effects in some diseases, such as asthma [ 11 ], rhinitis [ 12 ], and inflammatory bowel disease [ 13 ]. Acupuncture can treat these diseases by reducing the release of inflammatory substances.…”

Section: Introductionmentioning

confidence: 99%

The Effect of Transcutaneous Electrical Acupoint Stimulation on Inflammatory Response in Patients Undergoing Limb Ischemia-Reperfusion

Chen

Yang

et al. 2017

Mediators of Inflammation

View full text Add to dashboard Cite

Reperfusion after tourniquet use can induce inflammation and cause remote organ injury. We evaluated the therapeutic effect of transcutaneous electrical acupoint stimulation (TEAS) on inflammatory mediators and lung function in patients receiving lower limb tourniquets. Forty patients undergoing unilateral lower extremity surgery with tourniquet were randomly assigned to two groups: the TEAS group and ischemia-reperfusion (I/R) group. The C-C motif chemokine ligand 2 (CCL2), C-X-C motif chemokine ligand 8 (CXCL8), interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α), and arterial blood gas analysis were measured preoperatively and 6 h after tourniquet removal. The levels of CXCL8, IL-1, IL-6, TNF-α, and CCL2 were significantly increased compared to baseline values in both groups, but the increase was significantly smaller in the TEAS group. In the TEAS group, the partial pressure of oxygen and arterial-alveolar oxygen tension ratio were significantly decreased, and the alveolar-arterial oxygen tension difference and respiratory index were significantly increased, compared to those in the I/R group at 6 h after reperfusion. In conclusion, TEAS diminished the upregulation of proinflammatory factors in response to lower limb ischemia-reperfusion and improved pulmonary gas exchange.

show abstract

“…However, there is insufficient research that investigates the effectiveness of combined CAM interventions in AR treatment. [11][12][13][14][15][16][17][18][19][20][21] In the outpatient department of the Korean Medicine clinic, multiple interventions are involved in the treatment procedure, whereas existing studies do not adequately address this pragmatic approach.…”

Section: Introductionmentioning

confidence: 99%

Combined Korean medicine therapies in children with allergic rhinitis

Chu¹,

Jang

Lee

et al. 2021

Medicine

View full text Add to dashboard Cite

Introduction: Allergic rhinitis (AR) is the third most prevalent disease in early and middle adolescence in South Korea and one of the most common allergic diseases worldwide. Due to the ineffectiveness and frequent side effects of conventional medications for AR (such as antihistamines, corticosteroids) complementary and alternative medical (CAM) therapies have been in the spotlight. Although previous clinical trials conducted on AR with CAM showed efficacy and safety, these research results have limitations in that they did not estimate the effectiveness of combining multiple interventions. In this respect, this study aims to investigate the efficacy and safety of combined Korean medicine therapy by establishing an observational registry study at 13 Korean medical clinics that specialize in treating pediatric rhinitis. Methods: This is a prospective, observational, registry study of adolescent patients with AR. After screening, eligible subjects will be allocated to the registry. The patients will undergo a 4-week treatment and a 4-week post-treatment follow-up. The primary outcome will be the change in the average total nasal symptom score evaluated from baseline to the end of treatment. The secondary outcomes will include the numerical range scale, quality of life questionnaire in Korean children with AR, and the Pediatric Allergic Disease Quality of Life Questionnaire. KiFDA 3.0 will be measured for explanatory application on adolescents. Medical cost data and characteristics of patients such as weight, height, and sex will be collected by researchers. Discussion: This is the first multi-center observational registry study to compare combined Korean medicine treatment for AR. The results of this study will shed light on the effectiveness and safety of Korean medicine treatments for the treatment of patients with AR. Trial registration: KCT0006625 (2021.09.30)/IRB approval: Kyung-hee University Institutional Review Board (approval number: KHSIRB-21-358-1 [NA]). Trial Status: Protocol version 1.2(2021.09.16).

show abstract

Acupuncture and allergic rhinitis

Cited by 17 publications

References 25 publications

Recent advances in allergic rhinitis

Recent advances in allergic rhinitis

The Effect of Transcutaneous Electrical Acupoint Stimulation on Inflammatory Response in Patients Undergoing Limb Ischemia-Reperfusion

Combined Korean medicine therapies in children with allergic rhinitis

Contact Info

Product

Resources

About